CollPlant has been utilizing its proprietary plant-based rhCollagen technology for tissue repair. The new division will further develop collagen-based bioink for use in 3D printers creating organs and tissues. The Ness Ziona, Israel–based company says it has 3D bioprinting collaborations with several large international companies.
“Over the last several months, we have substantially ramped up our activities in the 3D printing field leveraging biological ink that we are developing based on our rhCollagen technology,” CollPlant CEO Yehiel Tal said in a news release.
“The collagen protein is a key building block in connective tissues in the human body, and therefore is ideal for use as biological ink,” Tal said.